Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:38 PM
Ignite Modification Date:
2025-12-24 @ 2:38 PM
NCT ID:
NCT00359359
Eligibility Criteria:
Inclusion Criteria:
* Small-cell lung cancer
* Stage of extensive disease
* Adequate function of major organs and systems
* Use of highly effective birth control methods in females of child-bearing potential
Exclusion Criteria:
* Prior chemotherapy for small-cell lung cancer
* Prior surgical resection or radiotherapy for SCLC within at least 3 to 4 weeks prior to inclusion and with the exception of radiation of brain metastases
* Superior vena cava syndrome or obstruction of any vital structure
* Untreated malignant hypercalcemia; Extensive disease amenable to radiation therapy; Symptomatic brain metastases requiring whole-brain irradiation
* Known allergy or hypersensitivity to platinum-containing drugs
* Pregnancy or breast-feeding
* Use of any investigational drug within 4 weeks before start of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00359359
Study Brief:
Protocol Section:
NCT00359359